Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Small Cell Lung Cancer
Clinical trial register · Germany

Small Cell Lung Cancer Trials in Germany, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Essen 8 Berlin 6 Cologne 6 Dresden 5 Gauting 4

Small Cell Lung Cancer trials in Germany

14 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Boehringer Ingelheim
Phase 1/2
60
Mainz, Stuttgart
2026-10-28
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
SystImmune Inc.
Phase 3
550
Cologne, Essen, Halle
2026-08-04
Recruiting
Amgen
Phase 1
160
Dresden, Würzburg
2026-04-21
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Frankfurt am Main, Berlin, Cologne, Dresden, Halle, Hamburg
2025-11-30
Active, closed
Amgen
Phase 3
350
Chemnitz, Cologne, Dresden, Essen, Frankfurt am Main, Gauting, Großhansdorf, Kiel
2025-08-18
Recruiting
AIO-Studien-gGmbH
Phase 2
57
Berlin, Dresden, Essen, Flensburg, Frankfurt, Minden, München, Stuttgart
2025-01-01
Active, closed
Amgen
Phase 3
563
Cologne, Dresden, Essen, Gauting, Großhansdorf, Heidelberg, Münster, Würzburg
2024-06-05
Recruiting
Daiichi Sankyo
Phase 3
540
Berlin, Erfurt, Essen, Frankfurt, Frankfurt am Main, Gauting, Gera, Giessen
2024-05-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Essen, Göttingen, Würzburg
2024-02-20
Active, closed
Hoffmann-La Roche
Phase 3
660
Bad Berka, Berlin, Chemnitz, Essen, Georgsmarienhütte, Großhansdorf, Halle, Immenhausen
2021-11-18
Active, closed
AstraZeneca
Phase 3
730
Berlin, Cologne, Freiburg im Breisgau, Gauting, Heidelberg, Mainz, Münster, Oldenburg
2018-09-27
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/condition/small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Small Cell Lung Cancer.

How many Small Cell Lung Cancer trials are recruiting in Germany?

7 of the 14 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Small Cell Lung Cancer), 14 studies
PhaseStudiesRecruitingShare
Phase 39464.3%
Phase 12114.3%
Phase 22214.3%
Phase 1/2107.1%

Most active sponsors

Lead sponsors with the most studies (Small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Amgen51
AbbVie22
AIO-Studien-gGmbH11
AstraZeneca10
Boehringer Ingelheim10
Daiichi Sankyo11
Hoffmann-La Roche10
SystImmune Inc.11
Zai Lab (Shanghai) Co., Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.